STERIS (NYSE:STE) Releases FY 2025 Earnings Guidance

STERIS (NYSE:STE) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 9.050-9.250 for the period, compared to the consensus estimate of 9.160. The company issued revenue guidance of $5.5 billion-$5.5 billion, compared to the consensus revenue estimate of $5.5 billion. STERIS also updated its FY25 guidance to $9.05-$9.25 EPS.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. Piper Sandler upgraded STERIS from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $230.00 to $260.00 in a report on Thursday, October 24th. Needham & Company LLC restated a “hold” rating on shares of STERIS in a report on Friday. Stephens reaffirmed an “overweight” rating and issued a $260.00 target price on shares of STERIS in a research report on Thursday. KeyCorp increased their target price on STERIS from $255.00 to $265.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 3rd. Finally, StockNews.com lowered STERIS from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, October 29th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $253.00.

STERIS Stock Up 1.7 %

NYSE:STE traded up $3.69 during mid-day trading on Friday, hitting $219.19. The company had a trading volume of 1,071,783 shares, compared to its average volume of 490,598. The business has a fifty day simple moving average of $232.29 and a 200-day simple moving average of $227.79. The company has a current ratio of 2.33, a quick ratio of 1.49 and a debt-to-equity ratio of 0.35. STERIS has a 1 year low of $195.47 and a 1 year high of $248.24. The firm has a market capitalization of $21.62 billion, a price-to-earnings ratio of 50.04 and a beta of 0.85.

STERIS (NYSE:STE) last released its quarterly earnings data on Wednesday, November 6th. The medical equipment provider reported $2.14 EPS for the quarter, beating the consensus estimate of $2.11 by $0.03. STERIS had a return on equity of 13.91% and a net margin of 8.02%. The company had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same period last year, the company posted $2.03 earnings per share. The firm’s revenue was up 7.3% compared to the same quarter last year. Equities analysts forecast that STERIS will post 9.02 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 19th. Stockholders of record on Tuesday, November 19th will be given a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.04%. The ex-dividend date is Tuesday, November 19th. STERIS’s payout ratio is 52.05%.

Insider Transactions at STERIS

In other news, CFO Michael J. Tokich sold 23,332 shares of STERIS stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $247.00, for a total transaction of $5,763,004.00. Following the sale, the chief financial officer now directly owns 42,930 shares of the company’s stock, valued at approximately $10,603,710. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.14% of the company’s stock.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.